=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-07-31
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Medtronic plc (MDT)
CIK: 0001613103
--- Reporting Owner ---
Name: Martha Geoffrey
CIK: 0001560409
Role: Director, Officer (Chairman and CEO)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Ordinary Shares
Date: 2026-07-31 | Code: F (Payment of exercise/tax)
Shares: -15,810 | Price: $85.39
Total Value: $1,350,015.90
Shares Owned After: 286,333 | Ownership: D (Direct)
Footnotes:
[F1] Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
[F2] Includes 980 shares acquired through dividend reinvestment since the last report filed by the reporting person.
[Transaction #2]
Security: Ordinary Shares
Date: 2026-08-03 | Code: A (Grant or award)
Shares: +41,533 | Price: $0.00
Shares Owned After: 327,866 | Ownership: D (Direct)
Footnotes:
[F3] Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
--- Derivative Transactions ---
[Transaction #1]
Security: Performance Share Units
Date: 2026-08-03 | Code: A (Grant or award)
Shares: +103,831 | Price: $0.00
Shares Owned After: 103,831 | Ownership: D (Direct)
Footnotes:
[F4] Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
[F5] Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
[F5] Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
[F6] The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 103,831 shares will be issued. If maximum performance metrics are achieved, 249,194 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
[Transaction #2]
Security: Stock Option (Right to Buy)
Date: 2026-08-03 | Code: A (Grant or award)
Shares: +295,002 | Price: $0.00
Exercisable: N/A | Expires: 2036-08-03
Shares Owned After: 295,002 | Ownership: D (Direct)
Footnotes:
[F7] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
[Transaction #3]
Security: Stock Option (Right to Buy)
Date: 2026-08-03 | Code: A (Grant or award)
Shares: +273,150 | Price: $0.00
Exercisable: N/A | Expires: 2036-08-03
Shares Owned After: 273,150 | Ownership: D (Direct)
Footnotes:
[F7] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
--- Footnotes (Complete Index) ---
F1: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
F2: Includes 980 shares acquired through dividend reinvestment since the last report filed by the reporting person.
F3: Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
F4: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F5: Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
F6: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 103,831 shares will be issued. If maximum performance metrics are achieved, 249,194 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F7: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
--- Signature ---
/s/ /s/ Patricia Walesiewicz, attorney-in-fact (2026-08-04)
